{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:30:50Z","timestamp":1792611050271,"version":"4.5.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100013809","name":"Osteoporosis Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1016\/j.bone.2008.05.019","type":"journal-article","created":{"date-parts":[[2008,6,4]],"date-time":"2008-06-04T05:04:33Z","timestamp":1212555873000},"page":"653-662","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":137,"title":["Bolus or weekly zoledronic acid administration does not delay endochondral fracture repair but weekly dosing enhances delays in hard callus remodeling"],"prefix":"10.1016","volume":"43","author":[{"given":"Michelle M.","family":"McDonald","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukhdeep","family":"Dulai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Godfrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Negin","family":"Amanat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Sztynda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.","family":"Little","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.bone.2008.05.019_bib1","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1138\/20070271","article-title":"Bisphosphonate treatment and fracture repair","volume":"4","author":"McDonald","year":"2007","journal-title":"BoneKEy Osteovision"},{"key":"10.1016\/j.bone.2008.05.019_bib2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0149-2918(03)90005-1","article-title":"Effect of daily and intermittent use of ibandronate on bone mass and bone turnover in postmenopausal osteoporosis: a review of three phase II studies","volume":"25","author":"Schimmer","year":"2003","journal-title":"Clin. Ther."},{"key":"10.1016\/j.bone.2008.05.019_bib3","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa067312","article-title":"Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis","volume":"356","author":"Black","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2008.05.019_bib4","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1359\/jbmr.061001","article-title":"Long term control of bone turnover in pagets disease with zoledronic acid and risedronate","volume":"22","author":"Hosking","year":"2006","journal-title":"J. Bone. Miner. Res."},{"key":"10.1016\/j.bone.2008.05.019_bib5","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1136\/bmj.327.7413.469","article-title":"Systematic review of role of bisphosphonates on skeletal morbidity in metastatic cancer","volume":"327","author":"Ross","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.bone.2008.05.019_bib6","first-page":"1","article-title":"Therapeutic equivalence of alendronate 70 mg once-weekly and alendronate 10 mg daily in the treatment of osteoporosis. Alendronate Once-Weekly Study Group","volume":"12","author":"Schnitzer","year":"2000","journal-title":"Aging (Milano)"},{"key":"10.1016\/j.bone.2008.05.019_bib7","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00774-006-0706-z","article-title":"Efficacy and tolerability of once-weekly administration of 17.5 mg risedronate in Japanese patients with involutional osteoporosis: a comparison with 2.5-mg once-daily dosage regimen","volume":"24","author":"Kishimoto","year":"2006","journal-title":"J. Bone. Miner. Metab."},{"key":"10.1016\/j.bone.2008.05.019_bib8","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0002-9343(97)00249-0","article-title":"Three monthly intravenous injections of ibandronate in the treatment of postmenopausal osteoporosis","volume":"103","author":"Thiebaud","year":"1997","journal-title":"Am. J. Med."},{"key":"10.1016\/j.bone.2008.05.019_bib9","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1359\/jbmr.1999.14.10.1768","article-title":"Intermittent and continuous administration of the bisphosphonate ibandronate in ovariohysterectomized beagle dogs: effects on bone morphometry and mineral properties","volume":"14","author":"Monier-Faugere","year":"1999","journal-title":"J. Bone. Miner. Res."},{"key":"10.1016\/j.bone.2008.05.019_bib10","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/000164700317413193","article-title":"Clodronate increases mineralization of callus after Colles' fracture: a randomized, double-blind, placebo-controlled, prospective trial in 32 patients","volume":"71","author":"Adolphson","year":"2000","journal-title":"Acta Orthop. Scand."},{"key":"10.1016\/j.bone.2008.05.019_bib11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.vascn.2003.11.003","article-title":"New model for simulation of fracture repair in full-grown beagle dogs: model characterization and results from a long-term study with ibandronate","volume":"50","author":"Bauss","year":"2004","journal-title":"J. Pharmacol. Toxicol. Methods."},{"issue":"Suppl 7","key":"10.1016\/j.bone.2008.05.019_bib12","first-page":"S53","article-title":"Use of a bisphosphonate (pamidronate) to modulate fracture repair in ovine bone","volume":"5","author":"Goodship","year":"1994","journal-title":"Ann Oncol"},{"key":"10.1016\/j.bone.2008.05.019_bib13","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/00003086-200303000-00036","article-title":"Long-term administration of clodronate does not prevent fracture healing in rats","author":"Koivukangas","year":"2003","journal-title":"Clin. Orthop."},{"key":"10.1016\/j.bone.2008.05.019_bib14","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/jbmr.2001.16.3.429","article-title":"Long-term effect of incadronate disodium (YM-175) on fracture healing of femoral shaft in growing rats","volume":"16","author":"Li","year":"2001","journal-title":"J. Bone. Miner. Res."},{"key":"10.1016\/j.bone.2008.05.019_bib15","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1359\/jbmr.2000.15.10.2042","article-title":"Concentration of bisphosphonate (incadronate) in callus area and its effects on fracture healing in rats","volume":"15","author":"Li","year":"2000","journal-title":"J. Bone. Miner. Res."},{"key":"10.1016\/j.bone.2008.05.019_bib16","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1359\/jbmr.1999.14.6.969","article-title":"Effect of bisphosphonate (incadronate) on fracture healing of long bones in rats","volume":"14","author":"Li","year":"1999","journal-title":"J. Bone. Miner. Res."},{"key":"10.1016\/j.bone.2008.05.019_bib17","doi-asserted-by":"crossref","first-page":"532","DOI":"10.3109\/17453679808997793","article-title":"No adverse effects of clodronate on fracture healing in rats","volume":"69","author":"Madsen","year":"1998","journal-title":"Acta. Orthop. Scand."},{"key":"10.1016\/j.bone.2008.05.019_bib18","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/BF00451880","article-title":"Clodronate increases the calcium content in fracture callus. An experimental study in rats","volume":"112","author":"Nyman","year":"1993","journal-title":"Arch. Orthop. Trauma. Surg."},{"key":"10.1016\/j.bone.2008.05.019_bib19","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/jor.1100140113","article-title":"Effect of alendronate on fracture healing and bone remodeling in dogs","volume":"14","author":"Peter","year":"1996","journal-title":"J. Orthop. Res."},{"key":"10.1016\/j.bone.2008.05.019_bib20","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1302\/0301-620X.83B7.0831069","article-title":"Intravenous pamidronate reduces osteoporosis and improves formation of the regenerate during distraction osteogenesis. A study in immature rabbits","volume":"83","author":"Little","year":"2001","journal-title":"J. Bone Joint Surg. Br."},{"key":"10.1016\/j.bone.2008.05.019_bib21","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1359\/jbmr.2003.18.7.1300","article-title":"Zoledronic acid prevents osteopenia and increases bone strength in a rabbit model of distraction osteogenesis","volume":"18","author":"Little","year":"2003","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2008.05.019_bib22","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.orthres.2005.03.004","article-title":"A single systemic dose of pamidronate improves bone mineral content and accelerates restoration of strength in a rat model of fracture repair","volume":"23","author":"Amanat","year":"2005","journal-title":"J. Orthop. Res."},{"key":"10.1016\/j.bone.2008.05.019_bib23","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1359\/jbmr.070318","article-title":"Optimal timing of a single dose of zoledronic acid to increase strength in rat fracture repair","volume":"22","author":"Amanat","year":"2007","journal-title":"J Bone and Min Res."},{"key":"10.1016\/j.bone.2008.05.019_bib24","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1210\/jc.2004-0952","article-title":"Severely suppressed bone turnover: a potential complication of alendronate therapy","volume":"90","author":"Odvina","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2008.05.019_bib25","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1359\/JBMR.040814","article-title":"Delayed osteotomy but not fracture healing in pediatric osteogenesis imperfecta patients receiving pamidronate","volume":"19","author":"Munns","year":"2004","journal-title":"J. Bone. Miner. Res."},{"key":"10.1016\/j.bone.2008.05.019_bib26","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1359\/jbmr.2001.16.3.437","article-title":"Can bisphosphonates be given to patients with fractures?","volume":"16","author":"Fleisch","year":"2001","journal-title":"J. Bone. Miner. Res."},{"issue":"10 Suppl","key":"10.1016\/j.bone.2008.05.019_bib27","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1097\/00005131-200511101-00002","article-title":"The science of fracture healing","volume":"19","author":"Einhorn","year":"2005","journal-title":"J. Orthop. Trauma. Nov-Dec."},{"key":"10.1016\/j.bone.2008.05.019_bib28","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S8756-3282(00)00414-2","article-title":"Osteoporosis influences the early period of fracture healing in a rat osteoporotic model","volume":"28","author":"Namkung-Matthai","year":"2001","journal-title":"Bone"},{"key":"10.1016\/j.bone.2008.05.019_bib29","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0736-0266(00)90034-2","article-title":"Age and ovariectomy impair both the normalization of mechanical properties and the accretion of mineral by the fracture callus in rats","volume":"19","author":"Meyer","year":"2001","journal-title":"J. Orthop. Res."},{"key":"10.1016\/j.bone.2008.05.019_bib30","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/00003086-199709000-00029","article-title":"Fracture healing in a rat osteopenia model","volume":"342","author":"Walsh","year":"1997","journal-title":"Clin. Orthop. Relat. Res."},{"key":"10.1016\/j.bone.2008.05.019_bib31","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1359\/jbmr.2002.17.6.998","article-title":"Dissociation of angiogenesis and osteoclastogenesis during endochondral bone formation in neonatal mice","volume":"17","author":"Deckers","year":"2002","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2008.05.019_bib32","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0925-4773(97)00203-7","article-title":"Recapitulation of signals regulating embryonic bone formation during postnatal growth and in fracture repair","volume":"71","author":"Vortkamp","year":"1998","journal-title":"Mech. Dev."},{"key":"10.1016\/j.bone.2008.05.019_bib33","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/jor.1100020115","article-title":"Production of a standard closed fracture in laboratory animal bone","volume":"2","author":"Bonnarens","year":"1984","journal-title":"J. Orthop. Res."},{"key":"10.1016\/j.bone.2008.05.019_bib34","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1359\/JBMR.050712","article-title":"Manipulation of the anabolic and catabolic responses with OP-1 and zoledronic acid in a rat critical defect model","volume":"20","author":"Little","year":"2005","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2008.05.019_bib35","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/8756-3282(93)90081-K","article-title":"Basic biomechanical measurements of bone: a tutorial","volume":"14","author":"Turner","year":"1993","journal-title":"Bone"},{"key":"10.1016\/j.bone.2008.05.019_bib36","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa074941","article-title":"Zoledronic acid and clinical fractures and mortality after hip fracture","author":"Lyles","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2008.05.019_bib37","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S8756-3282(02)00974-2","article-title":"Alendronate affects long bone length and growth plate morphology in the oim mouse model for Osteogenesis Imperfecta","volume":"32","author":"Evans","year":"2003","journal-title":"Bone"},{"key":"10.1016\/j.bone.2008.05.019_bib38","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S8756-3282(98)00033-7","article-title":"Bisphosphonates stimulate formation of osteoblast precursors and mineralized nodules in murine and human bone marrow cultures in vitro and promote early osteoblastogenesis in young and aged mice in vivo","volume":"22","author":"Giuliani","year":"1998","journal-title":"Bone"},{"key":"10.1016\/j.bone.2008.05.019_bib39","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.2174\/1381612033453640","article-title":"New insights into the molecular mechanisms of action of bisphosphonates","volume":"9","author":"Rogers","year":"2003","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bone.2008.05.019_bib40","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S8756-3282(01)00655-X","volume":"30","author":"Van Beek","year":"2002","journal-title":"Bone"},{"key":"10.1016\/j.bone.2008.05.019_bib41","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S8756-3282(99)00116-7","article-title":"Bisphosphonates: from the laboratory to the clinic and back again","volume":"25","author":"Russell","year":"1999","journal-title":"Bone"},{"key":"10.1016\/j.bone.2008.05.019_bib42","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1196\/annals.1402.089","article-title":"Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy","volume":"1117","author":"Russel","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bone.2008.05.019_bib43","doi-asserted-by":"crossref","DOI":"10.1007\/s00198-007-0540-8","article-title":"Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy","author":"Russell","year":"2008","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2008.05.019_bib44","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1359\/jbmr.071207","article-title":"Long-term protective effects of zoledronic acid on cancellous and cortical bone in the ovariectomized rat","volume":"23","author":"Gasser","year":"2008","journal-title":"J. Bone. Miner. Res."},{"key":"10.1016\/j.bone.2008.05.019_bib45","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1172\/JCI200422087","article-title":"An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis","volume":"114","author":"Giraudo","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2008.05.019_bib46","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1242\/dev.00559","article-title":"Altered fracture repair in the absence of MMP9","volume":"130","author":"Colnot","year":"2003","journal-title":"Development"},{"key":"10.1016\/j.bone.2008.05.019_bib47","doi-asserted-by":"crossref","first-page":"e1150","DOI":"10.1371\/journal.pone.0001150","article-title":"Role of matrix metalloproteinase 13 in both endochond0072al and intramembranous ossification during skeletal regeneration","volume":"11","author":"Behnonick","year":"2007","journal-title":"PLos One"},{"key":"10.1016\/j.bone.2008.05.019_bib48","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/S0736-0266(03)00011-1","article-title":"Effects of receptor activator of NFkappaB (RANK) signaling blockade on fracture healing","volume":"21","author":"Flick","year":"2003","journal-title":"J. Orthop. Res."},{"key":"10.1016\/j.bone.2008.05.019_bib49","article-title":"The effects of RANKL inhibition on fracture healing and bone strength in a mouse model of osteogenesis imperfecta","author":"Delos","year":"2007","journal-title":"J. Orthop. Res."},{"key":"10.1016\/j.bone.2008.05.019_bib50","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00223-001-2048-0","article-title":"The degree of mineralization of bone tissue measured by computerized quantitative contact microradiography","volume":"70","author":"Boivin","year":"2002","journal-title":"Calcif. Tissue. Int."},{"key":"10.1016\/j.bone.2008.05.019_bib51","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/S0021-9290(03)00124-6","article-title":"The many adaptations of bone","volume":"36","author":"Currey","year":"2003","journal-title":"J. Biomech."},{"key":"10.1016\/j.bone.2008.05.019_bib52","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S8756-3282(01)00575-0","article-title":"Effects of high-dose etidronate treatment on microdamage accumulation and biomechanical properties in beagle bone before occurrence of spontaneous fractures","volume":"29","author":"Mashiba","year":"2001","journal-title":"Bone"},{"key":"10.1016\/j.bone.2008.05.019_bib53","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1359\/jbmr.2002.17.12.2237","article-title":"Raloxifene, estrogen, and alendronate affect the processes of fracture repair differently in ovariectomized rats","volume":"17","author":"Cao","year":"2002","journal-title":"J. Bone. Miner. Res."},{"key":"10.1016\/j.bone.2008.05.019_bib54","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1359\/JBMR.040709","article-title":"Transient retention of endochondral cartilaginous matrix with bisphosphonate treatment in a long-term rabbit model of distraction osteogenesis","volume":"19","author":"Smith","year":"2004","journal-title":"J. Bone. Miner. Res."},{"key":"10.1016\/j.bone.2008.05.019_bib55","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2106\/JBJS.G.01585","article-title":"Selection and development of preclinical models in fracture healing research","volume":"90","author":"O'Loughlin","year":"2008","journal-title":"J. Bone. and. Joint. Surg. Am."},{"key":"10.1016\/j.bone.2008.05.019_bib56","article-title":"PTH and Alendronate improve osteotomy healing in an osteoporotic rat model","author":"Toro","year":"2006","journal-title":"Trans Orthopedic Research Society"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328208002731?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328208002731?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T03:36:33Z","timestamp":1762659393000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328208002731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S8756328208002731"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2008.05.019","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1123142.580196","asserted-by":"object"}]},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bolus or weekly zoledronic acid administration does not delay endochondral fracture repair but weekly dosing enhances delays in hard callus remodeling","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2008.05.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}